Medicine & Life Sciences
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
12%
Adapalene
9%
Albumin-Bound Paclitaxel
10%
Antimony Sodium Gluconate
9%
B-Cell Chronic Lymphocytic Leukemia
17%
Bed Rest
7%
Blood Cells
9%
Bone Marrow
13%
Bone Marrow Cells
12%
Breast Neoplasms
63%
Cachexia
7%
Capecitabine
7%
Cell Count
8%
Chimeric Antigen Receptors
8%
Circulating Neoplastic Cells
100%
Clinical Studies
8%
Cytokines
18%
Dendritic Cells
7%
Drug Therapy
7%
Epithelial-Mesenchymal Transition
26%
Immunosuppressive Agents
10%
Inflammation
8%
Inflammatory Breast Neoplasms
64%
Interleukin-8
9%
Lenalidomide
18%
MDV 3100
8%
Mesenchymal Stem Cells
11%
Microfluidics
9%
Multiple Myeloma
12%
Neoplasm Metastasis
8%
Neoplasms
25%
Neoplastic Stem Cells
28%
Non-Small Cell Lung Carcinoma
11%
Phenotype
8%
Physiological Adaptation
8%
Polymerase Chain Reaction
7%
Protein Tyrosine Phosphatases
7%
Radiation
8%
Residual Neoplasm
13%
Serum
9%
Sialyl Lewis X Antigen
9%
Space Flight
8%
Subunit Vaccines
7%
Syntaxin 1
9%
T-Lymphocytes
8%
Thalidomide
7%
Thrombocytosis
8%
Transplants
7%
Triple Negative Breast Neoplasms
15%
Tumor Microenvironment
14%